FDA Approves New Treatment for Rare Hunter Syndrome

Families dealing with Hunter syndrome just gained a powerful new treatment option after the FDA granted accelerated approval to Denali Therapeutics' groundbreaking drug.

The decision marks a turning point for rare disease patients after a year of tougher regulatory outcomes.